염증 마커 시장 규모, 점유율 및 성장 분석 : 마커 유형별, 기술별, 용도별, 최종사용자별, 샘플 유형별, 지역별 - 업계 예측(2026-2033년)

Global Inflammatory Marker Market size was valued at USD 6.28 Billion in 2024 and is poised to grow from USD 6.78 Billion in 2025 to USD 12.45 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The global inflammatory marker market is primarily driven by diagnostic assays, kits, and platforms that measure biomarkers such as C-reactive protein, interleukin-6, and tumor necrosis factor-a to assess disease activity. The growing prevalence of chronic diseases, including rheumatoid arthritis, cardiovascular conditions, and infectious diseases, underscores the necessity for early detection, which enhances therapeutic decision-making and patient outcomes. The incorporation of inflammatory markers into personalized medicine and drug development intensifies the demand for precise, high-throughput assays essential for patient stratification and response monitoring. The rise of AI-driven automation is revolutionizing the measurement of inflammatory markers by optimizing laboratory processes, enhancing result reliability, and streamlining workflows across various healthcare settings, thereby facilitating advanced multiplex platforms and decentralized testing initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inflammatory Marker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inflammatory Marker Market Segments Analysis

The global inflammatory marker market is segmented by marker type, technology, application, end user, sample type and region. Based on marker type, the market is segmented into C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Procalcitonin (PCT), Interleukins and Tumor Necrosis Factor (TNF). Based on technology, the market is segmented into Immunoassay, ELISA, PCR-Based Assays and Multiplex Assays. Based on application, the market is segmented into Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases and Oncology. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories and Research Institutes. Based on sample type, the market is segmented into Blood, Serum, Plasma and Other Biological Fluids. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inflammatory Marker Market

The Global Inflammatory Marker market is experiencing significant growth as healthcare providers increasingly recognize the critical role of inflammatory markers in early disease detection, risk assessment, and monitoring therapeutic efficacy. This growing confidence in the clinical application of these biomarkers is driving up demand for reliable testing kits, prompting manufacturers to diversify their product offerings and invest in educational initiatives. As clinicians integrate these markers into routine practice, the frequency of referrals increases, encouraging laboratories to adopt advanced platforms. These platforms typically offer enhanced sensitivity and expedited reporting, fueling the market's expansion and facilitating better patient management outcomes as inflammatory markers become more widely incorporated into standard clinical protocols.

Restraints in the Global Inflammatory Marker Market

The Global Inflammatory Marker market faces significant challenges due to the high costs associated with advanced testing methods. These methods often require intricate instruments, specialized reagents, and stringent quality controls, leading to elevated purchase and operational expenses. As a result, many healthcare facilities, especially those with constrained budgets, may delay investments or limit the number of tests conducted in order to manage costs effectively. This financial pressure hinders widespread adoption of these tests, particularly affecting smaller laboratories and emerging markets with limited funding. Consequently, the slow market penetration restricts the perceived clinical value, and financial obstacles also inhibit research institutions from expanding their assay offerings, further stunting market growth.

Market Trends of the Global Inflammatory Marker Market

The Global Inflammatory Marker market is witnessing a notable trend toward the adoption of multiplexed inflammatory panels that integrate cytokine and chemokine assessments alongside acute-phase protein measurements. This shift facilitates more refined disease stratification and supports personalized therapeutic strategies, particularly in complex cases where inflammatory signals may be ambiguous. The recognition that inflammatory pathways differ across various conditions, including autoimmune disorders and cardiovascular diseases, underpins this trend. Concurrently, laboratories are enhancing their operations through automation and advanced data analytics, which elevate the perceived value of comprehensive biomarker profiling and stimulate broader reimbursement discussions and collaborations between diagnostic manufacturers and healthcare providers worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Inflammatory Marker Market Size by Marker Type & CAGR (2026-2033)

• Market Overview
• C-Reactive Protein (CRP)
• Erythrocyte Sedimentation Rate (ESR)
• Procalcitonin (PCT)
• Interleukins
• Tumor Necrosis Factor (TNF)

Global Inflammatory Marker Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay
• ELISA
• PCR-Based Assays
• Multiplex Assays

Global Inflammatory Marker Market Size by Application & CAGR (2026-2033)

• Market Overview
• Autoimmune Diseases
• Infectious Diseases
• Cardiovascular Diseases
• Oncology

Global Inflammatory Marker Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes

Global Inflammatory Marker Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood
• Serum
• Plasma
• Other Biological Fluids

Global Inflammatory Marker Market Size & CAGR (2026-2033)

• North America (Marker Type, Technology, Application, End User, Sample Type)
  • US
  • Canada
• Europe (Marker Type, Technology, Application, End User, Sample Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Marker Type, Technology, Application, End User, Sample Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Marker Type, Technology, Application, End User, Sample Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Marker Type, Technology, Application, End User, Sample Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations